About this source
- Kind
- Regulatory or official document
- Primary or secondary
- primary
- Peer review
- not peer reviewed
- Retraction status
- None known
- Date checked
- 14 November 2026
Limitations
Manufacturer-authored text approved by the regulator. The eMC listing was last updated on 11 April 2025 and the SmPC text was revised on 22 January 2024. It describes a licensed product and is not itself a study.
Cited in
Mechanism of action
Abaloparatide · Research finding
Heart rate, blood pressure and kidney stones
Abaloparatide · Safety finding
Osteosarcoma in rats
Abaloparatide · Safety finding
UK regulatory status
Abaloparatide · UK regulatory status
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.